A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
Clinical trial NCT06754605 · RECRUITING
Trial details
- NCT number
- NCT06754605
- Sponsor
- Sinocelltech Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-06
- Primary completion
- 2027-07-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.